Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Middle East Conflict Threatens Global Economic Stability, World Bank Warns
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Bank of America Maintains Forecast for Two Fed Rate Cuts in 2026 Despite Inflation Risks
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Asia FX Weekly Gains Hold Amid U.S. Inflation Data and Iran Ceasefire Uncertainty
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Oil Prices Rebound as Hormuz Disruptions and Middle East Tensions Rattle Markets
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Asian Stocks Rally on Ceasefire Hopes and Bargain Buying
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
U.S. Markets Post Strong Weekly Gains Despite Middle East Tensions and Rising Energy Prices
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 



